The 2025-2030 World Outlook for Synthetic Opioids - Image 1

Out of stock

This item is currently unavailable

The 2025-2030 World Outlook for Synthetic Opioids

Subjects

Out of stock

Price data last checked 15 day(s) ago - will refresh soon

View at Amazon

One email. No newsletter. No nudges.

Gone for 273 days. Could come back at any time — we're watching for you.

Out of stock 273 days · last price £790 · longest previous gap was 1 days

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 389 days · 389 data points (no recent data)

Historical

Generating forecast…

Price Distribution

Price distribution over 389 days • 1 price levels

Days at Price

Price Analysis

Most common price: £790 (389 days, 100.0%)

Price range: £790 - £790

Price levels: 1 different prices over 389 days

Description

This study covers the world outlook for synthetic opioids across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models which project fundamental economic dynamics within each country and across countries, latent demand estimates are created. This report does not discuss the specific players in the market serving the latent demand, nor specific details at the product level. The study also does not consider short-term cyclicalities that might affect realized sales. The study, therefore, is strategic in nature, taking an aggregate and long-run view, irrespective of the players or products involved. In this report we define the sales of synthetic opioids as including all commonly understood products and/or services falling within this broad category, irrespective of product packaging, formulation, size, or form. Companies participating in this industry include Endo International, Impax Laboratories, Indivior, Janssen Pharmaceuticals, Mallinckrodt Pharmaceuticals, PLC, Mylan NV, Pfizer, Purdue Pharma, Teva Pharmaceuticals, and West-Ward Pharmaceuticals (Hikma’s US subsidiary). In addition to the sources indicated, additional information available to the public via news and/or press releases published by players in the industry was considered in defining and calibrating this category. All figures are in a common currency (U.S. dollars, millions) and are not adjusted for inflation (i.e., they are current values). Exchange rates used to convert to U.S. dollars are averages for the year in question. Future exchange rates are assumed to be constant in the future at the current level (the average of the year of this publication's release in 2024).

Product Specifications

Format: paperback
ASIN: B0CZLYGSLR
Category: Books > Subjects
Domain: Amazon UK
Release Date: 03 March 2024
Listed Since: 06 May 2024

The 2025-2030 World Outlook for Synthetic Opioids

Gone for 273 days. Could come back at any time — we're watching for you.

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Similar Products You Might Like

The 2025-2030 World Outlook for Opioids

The 2023-2028 Outlook for Opioids in the United States

The 2023-2028 Outlook for Opioid Drugs in the United States

The 2021-2026 World Outlook for Opium and Opium-Derivative Narcotic Internal Analgesic and Antipyretic Pharmaceutical Preparations

The 2023-2028 Outlook for Opioid Use Disorders in the United States

The 2023-2028 Outlook for Opioid Use Disorders in India

The 2023-2028 Outlook for Opioid Use Disorders in Japan

The 2023-2028 Outlook for Medical Devices for Opioid Use Disorder and Drug Addiction Treatments in the United States

The 2016-2021 Outlook for Opium and Opium-Derivative Narcotic Internal Analgesic and Antipyretic Pharmaceutical Preparations in the United States

The 2016-2021 Outlook for Opium and Opium-Derivative Narcotic Internal Analgesic and Antipyretic Pharmaceutical Preparations in Japan

The 2013-2018 Outlook for Opium and Opium-Derivative Narcotic Internal Analgesic and Antipyretic Pharmaceutical Preparations in India

The 2016-2021 Outlook for Opium and Opium-Derivative Narcotic Internal Analgesic and Antipyretic Pharmaceutical Preparations in Greater China

The 2023-2028 Outlook for Opioid Use Disorders for US Zip Codes

The 2016 Report on Opium and Opium-Derivative Narcotic Internal Analgesic and Antipyretic Pharmaceutical Preparations: World Market Segmentation by City

Opioids: From Analgesic Use to Addiction

The 2023-2028 World Outlook for Systemic Analgesic Medications

The 2023-2028 Outlook for Systemic Analgesic Medications in China

Battling the Opioid Epidemic

The World Market for Opium Alkaloids, Their Derivatives, and Salts Thereof: A 2026 Global Trade Perspective

The 2023-2028 Outlook for Non-Opioid Pain Treatments in the United States

Opioids 360: A Multidisciplinary Examination of an American Tragedy

The 2023-2028 Outlook for Wearable Devices in Opioid Use Disorder and Drug Addiction Treatments in the United States

The 2023-2028 Outlook for Wearable Devices in Opioid Use Disorder and Drug Addiction Treatments in India

Endogenous Opioids: From Basic Science to Biopsychosocial Applications: 35 (Advances in Neurobiology, 35)